Lola-Jade Palmieri

4PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Jul 21, 2021
Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives.

Lisa Lellouche, Lola-Jade Palmieri, Solène Dermine

|Jun 19, 2020
Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms.

Lola-Jade Palmieri, Solène Dermine, Amélie Barré

Pageof 1